Cyrex Alzheimer’s LINX™ — Alzheimer’s Immune Reactivity Panel

Description

Cyrex Alzheimer’s LINX™

Alzheimer’s LINX™ is a breakthrough early-detection panel that identifies immune reactivity against proteins associated with Alzheimer’s disease and neurodegeneration — years or decades before cognitive symptoms appear. It is the first multi-plex blood test designed for pre-clinical Alzheimer’s risk stratification in a functional medicine context.

Antigens Tested (IgG + IgA):

• Amyloid Beta 1-42 — hallmark Alzheimer’s plaque protein
• Phosphorylated Tau (p-Tau 181, p-Tau 231) — neurofibrillary tangle proteins
• RAGE (Receptor for Advanced Glycation End-products)
• Alpha-Synuclein (Parkinson’s/Lewy body overlap)
• TDP-43 (frontotemporal neurodegeneration marker)
• SOD1 (ALS-associated oxidative stress marker)
• Neurofilament Light Chain (NfL) — pan-neuronal damage

Sample Type:

Blood serum — single blood draw.

Ref: HSE1573